Why This Pharmaceutical Stock Jumped Almost 100% This Week
A mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
Review fee comparisons across wide market index funds to find the lowest-cost option for retirement. Practical guidance to reduce recurring expenses.
28,610 articlesA mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
Carvana’s eye-popping ascent sparked debates about online car shopping and disruption. As Amazon weighs in on automot...
California's governor signs a bold policy to curb insider moves in prediction markets. The move, framed as protecting...
Citigroup and Wells Fargo chart different paths: one leans global and institutional, the other domestic and consumer-...
A high, steady dividend from Pfizer and peers draws inflows as retirees seek reliable income amid shifts in COVID-era...
Palantir has a unique data platform and government-commercial mix. This guide outlines how the business could evolve,...
A deadly cattle parasite remains largely uncontained as a key sterile-fly facility won’t be online until late 2027, r...
Apple secured a commanding lead in the 2026 chip race by locking more than half of TSMC's 2nm capacity, while Google ...
Pennsylvania's House is set to vote on HB 2120 to bring home equity investment contracts under state banking oversigh...
A midrange, budget-friendly Apple device could broaden the company’s market and boost services revenue. This guide an...
Maestro has gone live on Robinhood Chain, bringing its Telegram-first trading bot to a fast-moving Arbitrum layer-2. ...
The AI rush has put NVIDIA and TSMC in the spotlight. This guide breaks down the opportunity, risks, and what it take...